---
figid: PMC9544065__BIOF-48-813-g011
figtitle: Revisiting the therapeutic potential of tocotrienol
organisms:
- Saccharomyces cerevisiae
- Nicotiana tabacum
- Oryza sativa
- Lareunionomyces loeiensis
- Triticum aestivum
- Hordeum vulgare
- eudicotyledons
- Catharanthus roseus
- Liliopsida
- Avena sativa
- Origanum vulgare
- Hevea brasiliensis
- Hippophae rhamnoides
- Elaeis guineensis
- Bixa orellana
- Triticum monococcum
- Terminalia bellirica
- Triticum turgidum subsp. dicoccum
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Canis lupus familiaris
- Homo sapiens
- Caenorhabditis elegans
- gut metagenome
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC9544065
filename: BIOF-48-813-g011.jpg
figlink: /pmc/articles/PMC9544065/figure/biof1873-fig-0012/
number: F12
caption: 'The common molecular mechanisms induced by tocotrienol therapy in experimental
  studies: Straight arrows indicate upregulation, and the dotted arrows show inhibition.
  TNF‐α—tumor necrosis factor‐alpha—a pro‐inflammatory cytokine—an inflammatory marker;
  FLIP—FLICE inhibitory protein—an inhibitor of apoptosis—a cytoplasmic protein complex
  which activates the inhibition of caspases; DR 4 & 5—death receptor 4 and 5; P‐53—A
  protein which acts as a tumor suppressor—inhibits uncontrolled cell proliferation;
  ROS—reactive oxygen species; ERK—extracellular signal‐regulated kinase; Bax—a member
  of the Bcl‐2 gene family which are nuclear encoded proteins which mediate apoptosis
  through mitochondrial activation; TRAIL—TNF‐related apoptosis‐inducing ligand—a
  protein ligand that induces cell death; PI3K—phosphoinositide 3—kinase, a protein
  which favors cellular functions in cancer; Akt—protein kinase (B)—a serine/threonine
  specific protein kinase—an enzyme which plays a key role in many cellular functions;
  NF‐kB—nuclear factor kappa beta‐pathway; PARP—poly‐ADP ribose polymerase—enables
  repair of DNA damage; Cezanne—deubiquitinating protein which inhibits NF‐kB translocation;
  TRAF3—a member of the TNF‐receptor associated factor protein family—which negatively
  regulates NF‐kB activity; RIP1P—receptor interacting serine/threonine‐protein kinase
  1—Induces apoptosis and necroptosis by participating in NF‐kB, Akt, and JNK pathways;
  TAK1—transforming growth factor‐beta‐activated kinase‐1—mediates NF‐kB, p38, and
  JNK pathways, JNKP‐phosphorylated c‐Jun‐N—terminal kinase—controls apoptosis and
  cell proliferation—A member of the MAPK—mitogen‐activated protein kinase pathway;
  IKBα, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor‐alpha—inhibits
  NF‐kB transcription; IKK—Inhibitor of upstream IKB kinase—inhibits IKB phosphorylation,
  degradation, subsequent NF‐kB nuclear translocation; p65—a subunit of NF‐kB nuclear
  transcription‐involved in inducing the NF‐kB pathway‐immunity, tumorigenesis, inflammation;
  p50—a component transcription factor of the NF‐kB pathway; ER—endoplasmic reticulum;
  elf2αP—phosphorylated eukaryotic translation initiation factor‐alpha‐subunit 1‐involved
  in translation in protein synthesis; A20—plays an anti‐tumorigenesis role in cancer'
papertitle: Revisiting the therapeutic potential of tocotrienol.
reftext: Ranmali Ranasinghe, et al. Biofactors. 2022 Jul-Aug;48(4):813-856.
year: '2022'
doi: 10.1002/biof.1873
journal_title: Biofactors (Oxford, England)
journal_nlm_ta: Biofactors
publisher_name: John Wiley & Sons, Inc.
keywords: antioxidant behavior | cancer studies | chemotherapy | disease pathology
  | tocotrienol in cancer immunology | tocotrienols | vitamin E
automl_pathway: 0.9534006
figid_alias: PMC9544065__F12
figtype: Figure
redirect_from: /figures/PMC9544065__F12
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9544065__BIOF-48-813-g011.html
  '@type': Dataset
  description: 'The common molecular mechanisms induced by tocotrienol therapy in
    experimental studies: Straight arrows indicate upregulation, and the dotted arrows
    show inhibition. TNF‐α—tumor necrosis factor‐alpha—a pro‐inflammatory cytokine—an
    inflammatory marker; FLIP—FLICE inhibitory protein—an inhibitor of apoptosis—a
    cytoplasmic protein complex which activates the inhibition of caspases; DR 4 &
    5—death receptor 4 and 5; P‐53—A protein which acts as a tumor suppressor—inhibits
    uncontrolled cell proliferation; ROS—reactive oxygen species; ERK—extracellular
    signal‐regulated kinase; Bax—a member of the Bcl‐2 gene family which are nuclear
    encoded proteins which mediate apoptosis through mitochondrial activation; TRAIL—TNF‐related
    apoptosis‐inducing ligand—a protein ligand that induces cell death; PI3K—phosphoinositide
    3—kinase, a protein which favors cellular functions in cancer; Akt—protein kinase
    (B)—a serine/threonine specific protein kinase—an enzyme which plays a key role
    in many cellular functions; NF‐kB—nuclear factor kappa beta‐pathway; PARP—poly‐ADP
    ribose polymerase—enables repair of DNA damage; Cezanne—deubiquitinating protein
    which inhibits NF‐kB translocation; TRAF3—a member of the TNF‐receptor associated
    factor protein family—which negatively regulates NF‐kB activity; RIP1P—receptor
    interacting serine/threonine‐protein kinase 1—Induces apoptosis and necroptosis
    by participating in NF‐kB, Akt, and JNK pathways; TAK1—transforming growth factor‐beta‐activated
    kinase‐1—mediates NF‐kB, p38, and JNK pathways, JNKP‐phosphorylated c‐Jun‐N—terminal
    kinase—controls apoptosis and cell proliferation—A member of the MAPK—mitogen‐activated
    protein kinase pathway; IKBα, nuclear factor of kappa light polypeptide gene enhancer
    in B cells inhibitor‐alpha—inhibits NF‐kB transcription; IKK—Inhibitor of upstream
    IKB kinase—inhibits IKB phosphorylation, degradation, subsequent NF‐kB nuclear
    translocation; p65—a subunit of NF‐kB nuclear transcription‐involved in inducing
    the NF‐kB pathway‐immunity, tumorigenesis, inflammation; p50—a component transcription
    factor of the NF‐kB pathway; ER—endoplasmic reticulum; elf2αP—phosphorylated eukaryotic
    translation initiation factor‐alpha‐subunit 1‐involved in translation in protein
    synthesis; A20—plays an anti‐tumorigenesis role in cancer'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BAX
  - BCL2
  - TP53
  - TP63
  - TP73
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - CFLAR
  - FIRRM
  - EPHB2
  - MAPK1
  - MAPK3
  - TNFSF10
  - OTUD7B
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TRAF3
  - TNF
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKBIA
  - MAP3K7
  - NR2C2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - EIF2A
  - EIF2S1
  - TNFAIP3
  - IGKV1-27
  - Akt1
  - Pik3r1
  - Bax
  - Nkx3-1
  - Bcl2
  - Trp53
  - Casp3
  - Parp1
  - Cflar
  - Firrm
  - Ephb2
  - Mapk1
  - Tnfsf10
  - Otud7b
  - Traf3
  - Tnf
  - Rela
  - Gorasp1
  - Nr2c2
  - Map3k7
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Mapk8
  - Eif2a
  - Eif2s1
  - Tnfaip3
  - Pik3cg
  - Tp53
  - Ephb1
  - Syt1
  - Eif2b1
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Debcl
  - p53
  - betaTub60D
  - hth
  - Decay
  - Parp
  - flip
  - Erk7
  - rl
  - Dr
  - MKP-4
  - p38b
  - Traf-like
  - egr
  - dl
  - wash
  - Tak1
  - Hrb27C
  - Rpt5
  - DCTN2-p50
  - Dif
  - Rel
  - bsk
  - eIF2alpha
  - eIF2A
---
